Sun Pharma to buy Japan’s branded portfolio of Novartis
Sun Pharma is all set to buy Japan’s branded portfolio of Novartis. Sources reveal that the 2500 crore deal between Sun Pharma and Novartis could be finalized by early December this year.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
